Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Report this comment to a moderator

Please fill in the form below if you think a comment is unsuitable. Please indicate which comment is of concern and why. Your comments will be sent to our moderator for review.

Report comment to moderator

MandatoryRequired fields.


UK trials not needed for medical cannabis licensing process, says Hancock


Peter, the Misuse of Drugs Act as it pertains to cannabis these days is a joke, as Trev Coleman says, the foundational evidence for cannabis being in schedule 1 (a dangerous drug with no accepted medical use) does not exist, is outdated and never was evidence based anyway, foundations and reasons for classification are important, Matt Hancock states in this article that cannabis doesn't have to go through clinical trials due to 'global evidence' and that evidence directly refutes schedule one status for cannabis, so despite what it might say in the missuse of drugs act, it is very much a grey area, we now know that our bodies make their own version of thc 'anandamide' so how can thc be addictive if our body makes a chemical that does the same job? I have to ask once again which side are you on Peter?

Posted date

17 JUL 2019

Posted time



Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.